EANM guideline on quality risk management for radiopharmaceuticals.

Humans Nuclear Medicine Radiopharmaceuticals / adverse effects Risk Management
Quality assurance Radiopharmaceuticals Risk assessment

Journal

European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988

Informations de publication

Date de publication:
08 2022
Historique:
received: 18 01 2022
accepted: 17 02 2022
pubmed: 8 4 2022
medline: 27 7 2022
entrez: 7 4 2022
Statut: ppublish

Résumé

This document is intended as a supplement to the EANM "Guidelines on current Good Radiopharmacy Practice (cGRPP)" issued by the Radiopharmacy Committee of the EANM (Gillings et al. in EJNMMI Radiopharm Chem. 6:8, 2021). The aim of the EANM Radiopharmacy Committee is to provide a document that describes how to manage risks associated with small-scale "in-house" preparation of radiopharmaceuticals, not intended for commercial purposes or distribution.

Identifiants

DOI: 10.1007/s00259-022-05738-4 PMID: 35385986 PMC: PMC9308578
pubmed: 35385986
doi: 10.1007/s00259-022-05738-4
pii: 10.1007/s00259-022-05738-4
pmc: PMC9308578
doi:

Substances chimiques

Radiopharmaceuticals 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3353-3364

Informations de copyright

© 2022. The Author(s).

Références

EJNMMI Radiopharm Chem. 2017;2(1):8
pubmed: 29503849
Nuklearmedizin. 2020 Apr;59(2):60-78
pubmed: 32126578
EJNMMI Radiopharm Chem. 2021 Feb 12;6(1):8
pubmed: 33580358

Auteurs

Nic Gillings (N)

Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.

Olaug Hjelstuen (O)

GE Healthcare, Pharmaceutical Diagnostics, Oslo, Norway.

Martin Behe (M)

Center for Radiopharmaceutical Sciences, Paul Scherrer Institute, Villigen, Switzerland.

Clemens Decristoforo (C)

Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.

Philip H Elsinga (PH)

Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands.

Valentina Ferrari (V)

MSD Animal Health, Milton Keynes, UK.

Oliver C Kiss (OC)

Department of Radiopharmaceuticals Production, Institute for Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany. o.kiss@hzdr.de.
ORCID: 0000-0001-7431-0026

Petra Kolenc (P)

Department of Nuclear Medicine and Faculty of Pharmacy, University Medical Centre Ljubljana and University of Ljubljana, Ljubljana, Slovenia.

Jacek Koziorowski (J)

Independent Consultant, Linköping, Sweden.

Peter Laverman (P)

Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands.

Thomas L Mindt (TL)

Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria.

Meltem Ocak (M)

Department of Pharmaceutical Technology, Istanbul University, Istanbul, Turkey.

Marianne Patt (M)

Department for Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.

Sergio Todde (S)

Tecnomed Foundation, University of Milano-Bicocca, Monza, Italy.

Almut Walte (A)

Department of Nuclear Medicine, Hannover Medical School, Hanover, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › EANM guideline on quality risk management for...
questionsmedicales.fr › Professions de santé › Médecine › Radiologie › Médecine nucléaire › EANM guideline on quality risk management for...
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits chimiques de laboratoire › Indicateurs et réactifs › Radiopharmaceutiques › EANM guideline on quality risk management for...
questionsmedicales.fr › Administration des services de santé › Organisation et administration › Gestion du risque › EANM guideline on quality risk management for...